Product Highlight – Somatuline
- The 1st and only Somatostatin analogue approved for pancreatic and midgut tumour control1.
- Significant prolonged progression free survival over deferred treatment2.
- Can make a difference as a 1st line anti-tumor therapy2.
- Single-use prefilled syringe, no reconstitution or mixing is required,suitable for self-administration3.
- Innovative syringe with retractable needle to prevent needle stick injury3.
- Somatuline Autogel UK SmPC 2015
- Caplin M et al., NEJM 2014, 371(3):224-233
- Johanson V, et al., Patient Preference and Adherence 2012, (6): 703-710
Further information is available in Section 6e, New in This Issue and mims.com.
Full prescribing information is available upon request.